We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lilly, Roche/Genentech Storm CMS in Support of Antiamyloid Antibodies
Lilly, Roche/Genentech Storm CMS in Support of Antiamyloid Antibodies
Eli Lilly and Roche/Genentech — both developers of antiamyloid antibodies for Alzheimer’s — have charged into the Aduhelm coverage war in defense of their own products.